AstraZeneca Extends License for Linguamatics Text-Mining Software | GenomeWeb

NEW YORK, Dec. 19 (GenomeWeb News) - AstraZeneca has extended its license for Linguamatics' text-mining software, the natural language processing company said today.

 

AstraZeneca signed the original license agreement in October 2003 to use the technology for its drug discovery and development programs.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.